CSL Of Australia's Among Four H1N1 Flu Vaccines Approved In U.S.
This article was originally published in PharmAsia News
Executive Summary
Australia's CSL was one of four H1N1 flu vaccine makers to win the approval of the FDA in the United States where authorities expect to have as many as 50 million doses available by mid-October